$VXRT Very interesting note by @Clecko! All of Vaxart’s prior BARDA Flu test PRs and presentation slides named Sanofi FluZone as who Vaxart was comparing their vax to in the Flu study. But, Interestingly the recent Stanford Flu study PR last week and the presentations (apparently according to Clecko) never once mentioned Sanofi FluZone. The Stanford correlates PR just mentioned words like “an injected quadrivalent” or “IIV”. They never said Sanofi FluZone… Very interesting given we know from recent presentations that they have ongoing partnership talks with Big Pharma and Sanofi’s Head of Legal US Vaccines has been liking Vaxart’s posts for months and FAST, like right after they posy. investors.vaxart.com/news-r...
14
34
@Clecko @Khunken @herbbrooks Again, HB nailed this right out of the gate moNath’s ago from the first “like”. You guys on this board are amazing! 1/2 VAXART’S ORAL VACCINE vs SANOFI’S FLUZONE: A Phase II head-to-head challenge study of Vaxart’s oral flu vaccine candidate versus Sanofi’s Fluzone shot and a placebo showed superior efficacy to Sanofi’s established product. Illness rates were 39% lower in those given Vaxart’s oral vaccine compared with unvaccinated subjects, and 27% lower than in those vaccinated with Fluzone scrip.pharmaintelligence.in...
3
3 Likes